Our founding team brings over 60 years of combined expertise across sensors, medical devices, biomarker technology, cancer research, and FDA regulatory pathways, including 20 years in startups and 20 years in manufacturing and operations. With a track record of launching groundbreaking products that have transformed markets, our leadership has consistently driven innovation and operational excellence, positioning us at the forefront of biotech, healthcare, and diagnostic advancements.
At Maggie’s Breath, our mission is personal — born from love, loss, and the belief that every woman deserves access to safe, early breast cancer detection.
We are developing a groundbreaking breath-based diagnostic technology that detects biomarkers associated with early-stage breast cancer — without pain, radiation, or invasive procedures. It’s fast, gentle, and backed by science.
Now in the pre-FDA approval phase, we are seeking visionary investors and strategic partners to help us bring this innovation to the women who need it most. Your investment will help complete clinical validation, accelerate regulatory approval, and scale access to communities worldwide.
📩 If you’re inspired to be part of a life-saving breakthrough, contact us at ssibani@maggiesbreath.com or fill out the form below.
Together, we can create a future where early detection is not a privilege, but a promise.
Be among the first to experience the future of Cancer Screening.
Subscribe to our email list for updates on our progress, to see if you're eligible for our clinical trials, and be the first to access Maggie's breath when it launches. Button to click and fill in the contact details.